These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18425099)

  • 1. Cross-presentation: avoiding trafficking chaos?
    Kasturi SP; Pulendran B
    Nat Immunol; 2008 May; 9(5):461-3. PubMed ID: 18425099
    [No Abstract]   [Full Text] [Related]  

  • 2. Escort service for cross-priming.
    Melief CJ
    Nat Immunol; 2005 Jun; 6(6):543-4. PubMed ID: 15908932
    [No Abstract]   [Full Text] [Related]  

  • 3. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
    Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
    Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular mechanisms of antigen cross presentation in dendritic cells.
    Amigorena S; Savina A
    Curr Opin Immunol; 2010 Feb; 22(1):109-17. PubMed ID: 20171863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells spill the beans.
    Watts C
    Nat Cell Biol; 1999 Oct; 1(6):E152-4. PubMed ID: 10559977
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic cells: open for presentation business.
    Saveanu L; van Endert P
    Nat Immunol; 2005 Jan; 6(1):7-8. PubMed ID: 15611772
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis.
    Pang B; Neijssen J; Qiao X; Janssen L; Janssen H; Lippuner C; Neefjes J
    J Immunol; 2009 Jul; 183(2):1083-90. PubMed ID: 19553546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exiting the outside world for cross-presentation.
    Rock KL
    Immunity; 2006 Oct; 25(4):523-5. PubMed ID: 17046678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTL induction by cross-priming is restricted to immunodominant epitopes.
    Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
    Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
    van Montfoort N; Camps MG; Khan S; Filippov DV; Weterings JJ; Griffith JM; Geuze HJ; van Hall T; Verbeek JS; Melief CJ; Ossendorp F
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6730-5. PubMed ID: 19346487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
    Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
    J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-priming.
    Bevan MJ
    Nat Immunol; 2006 Apr; 7(4):363-5. PubMed ID: 16550200
    [No Abstract]   [Full Text] [Related]  

  • 15. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells.
    Villadangos JA; Heath WR; Carbone FR
    Trends Immunol; 2007 Feb; 28(2):45-7. PubMed ID: 17197240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
    Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
    Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes.
    Homhuan A; Kogure K; Nakamura T; Shastri N; Harashima H
    J Control Release; 2009 May; 136(1):79-85. PubMed ID: 19344678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-presentation properties of plasmacytoid dendritic cells.
    Villadangos JA; Young L
    Immunity; 2008 Sep; 29(3):352-61. PubMed ID: 18799143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
    Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
    J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation. Chewing the fat.
    Parham P
    Nature; 1994 Dec; 372(6507):615-6. PubMed ID: 7527497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.